Elevated IGF2 levels may be beneficial in stabilizing blood glucose concentrations, such as in the intrauterine hyperglycemic environment in women with GDM, but the consequence of this process affecting weight gain probably leads to macrosomia, which is an adverse pregnancy outcome. The gene discussed is IGF2; the disease is Large for gestational age.